Home » Bayer’s Contested Kidney Cancer Drug Shows Benefit
Bayer’s Contested Kidney Cancer Drug Shows Benefit
September 22, 2009
Final results from a mid-stage clinical trial involving a sister compound to Bayer AG’s Nexavar have confirmed the drug’s potential, raising the stakes in a legal tussle with development partner Onyx Pharmaceuticals Inc.
CNBC
CNBC
Upcoming Events
-
21Oct